dimethoxyphenylethylamine has been researched along with glutamic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Marín, A; Gołembiowska, K; Herian, M; Skawski, M; Sobocińska, MK; Wojtas, A | 1 |
| Gołembiowska, K; Herian, M; Noworyta, K; Skawski, M; Sobocińska, MK; Wojtas, A | 1 |
| Bysiek, A; Gołembiowska, K; Herian, M; Maćkowiak, M; Madej, K; Solarz, A; Wawrzczak-Bargiela, A; Wojtas, A | 1 |
3 other study(ies) available for dimethoxyphenylethylamine and glutamic acid
| Article | Year |
|---|---|
Contribution of serotonin receptor subtypes to hallucinogenic activity of 25I-NBOMe and to its effect on neurotransmission.
Topics: Animals; Dimethoxyphenylethylamine; Dopamine; Frontal Lobe; Glutamic Acid; Hallucinogens; Male; Microdialysis; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Serotonin; Serotonin Receptor Agonists; Synaptic Transmission | 2020 |
Tolerance to neurochemical and behavioral effects of the hallucinogen 25I-NBOMe.
Topics: Animals; Brain Chemistry; Dimethoxyphenylethylamine; Dopamine; Frontal Lobe; Glutamic Acid; Hallucinogens; Locomotion; Male; Microdialysis; Rats; Rats, Wistar; Serotonin | 2021 |
Neurotoxicological profile of the hallucinogenic compound 25I-NBOMe.
Topics: Animals; Apoptosis; Blood-Brain Barrier; Brain; Dimethoxyphenylethylamine; DNA Damage; Dopamine; Glutamic Acid; Hallucinogens; Humans; Injections; Neuroglia; Oxidative Stress; Rats; Serotonin | 2022 |